Your browser doesn't support javascript.
loading
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Rovin, Brad H; Solomons, Neil; Pendergraft, William F; Dooley, Mary Anne; Tumlin, James; Romero-Diaz, Juanita; Lysenko, Lidia; Navarra, Sandra V; Huizinga, Robert B.
Afiliación
  • Rovin BH; Department of Internal Medicine-Nephrology, Ohio State University, Columbus, Ohio, USA. Electronic address: Brad.Rovin@osumc.edu.
  • Solomons N; Aurinia Pharmaceuticals, Victoria, Canada.
  • Pendergraft WF; University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA.
  • Dooley MA; University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA.
  • Tumlin J; GA Nephrology, Atlanta, Georgia, USA.
  • Romero-Diaz J; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Lysenko L; First Moscow State Medical University, Moscow, Russia.
  • Navarra SV; St. Luke's Medical Center and University of Santo Tomas Hospital, Philippines.
  • Huizinga RB; Aurinia Pharmaceuticals, Victoria, Canada.
Kidney Int ; 95(1): 219-231, 2019 01.
Article en En | MEDLINE | ID: mdl-30420324

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Ciclosporina / Inhibidores de la Calcineurina Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Kidney Int Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Ciclosporina / Inhibidores de la Calcineurina Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Kidney Int Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos